EUVIMEDEUVIMED entdecken
Crossref

AKAP1 in Renal Patients with AHF to Reduce Ferroptosis of Cardiomyocyte

Yifeng Fang, Junpeng Xu, Ruofei Huang

The Heart Surgery Forum · 2024

DOI: 10.59958/hsf.5717 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Heart Surgery Forum, 2024. Verfasst von Yifeng Fang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency, The First People's Hospital of Yongkang, 321390 Yongkang, Zhejiang, China. yifengfang@yeah.net. Hauptthemen laut MEDLINE: Ferroptosis, Heart Failure, A Kinase Anchor Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study mainly investigated the mechanism and effects of AKAP1 in renal patients with acute heart failure (AHF).

Methods

Patients with renal patients with AHF and normal volunteers were collected. The left anterior descending arteries (LAD) of mice were ligated to induce myocardial infarction.

Results

AKAP1 messenger RNA (mRNA) expression was found to be down-regulated in renal patients with AHF. The serum levels of AKAP1 mRNA expression were negatively correlated with collagen I/III in patients. AKAP1 mRNA and protein expression in the heart tissue of mice with AHF were also found to be down-regulated in a time-dependent manner. Short hairpin (Sh)-AKAP1 promotes AHF in a mouse model. AKAP1 up-regulation reduces reactive oxygen species (ROS)-induced oxidative stress in an In Vitro model. AKAP1 up-regulation also reduces ROS-induced lipid peroxidation ferroptosis in an In Vitro model. AKAP1 induces NDUFS1 expression to increase GPX4 activity levels. AKAP1 protein interlinked with the NDUFS1 protein. Up-regulation of the AKAP1 gene reduced NDUFS1 ubiquitination, while down-regulation of the AKAP1 gene increased NDUFS1 ubiquitination in a model. In vivo imaging showed that the sh-AKAP1 virus reduced NDUFS1 expression in the heart of a mouse model.

Conclusions

AKAP1 reduced ROS-induced lipid peroxidation ferroptosis through the inhibition of ubiquitination of NDUFS by mitochondrial damage in model of renal patients with AHF, suggest a novel target for AHF treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisHeart FailureA Kinase Anchor ProteinsAnimalsHumansMiceMyocytes, CardiacReactive Oxygen SpeciesRNA, MessengerNADH Dehydrogenase

Substanzen

Reactive Oxygen SpeciesRNA, MessengerAKAP1 protein, humanA Kinase Anchor ProteinsNDUFS1 protein, humanNADH Dehydrogenase

Autor:innen und Institutionen

  • Department of Emergency, The First People's Hospital of Yongkang, 321390 Yongkang, Zhejiang, China. yifengfang@yeah.net.
  • Department of Emergency, The First People's Hospital of Yongkang, 321390 Yongkang, Zhejiang, China. 815472447@qq.com.
  • Department of Endocrine, The First People's Hospital of Yongkang, 321390 Yongkang, Zhejiang, China. huangruofei@hmc.edu.cn.

Zitieren

APA

Fang, Y., Xu, J., & Huang, R. (2024). AKAP1 in Renal Patients with AHF to Reduce Ferroptosis of Cardiomyocyte. The Heart Surgery Forum. https://doi.org/10.59958/hsf.5717

Vancouver

Fang Y, Xu J, Huang R. AKAP1 in Renal Patients with AHF to Reduce Ferroptosis of Cardiomyocyte. The Heart Surgery Forum. 2024. doi:10.59958/hsf.5717

BibTeX
@article{Fang2024,
  author = {Fang, Yifeng and Xu, Junpeng and Huang, Ruofei},
  title = {AKAP1 in Renal Patients with AHF to Reduce Ferroptosis of Cardiomyocyte},
  journal = {The Heart Surgery Forum},
  year = {2024},
  doi = {10.59958/hsf.5717}
}
Kostenlos starten →